Acambis News
Most Popular Acambis Story
Universal flu vaccine shows early promise
Acambis has stirred a significant amount of buzz with some early-stage human data demonstrating the effectiveness of its universal flu vaccine. In the trial, nine out of 10 people developed... Read more...
Latest Headlines
- February 3, 2010
- September 25, 2008
- July 31, 2008
- April 24, 2008
- March 6, 2008
- January 10, 2008
- December 20, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
